Skip to content
Friends of Cancer Research
About
About Friends
Celebrating 25 Years
Team
Board of Directors
Financials & Policies
Projects
View All Projects
Research Partnerships
ctDNA
HRD Harmonization Project
Tumor Mutational Burden
Real-World Evidence
Policy & Regulatory Initiatives
Cell Therapies
Clinical Trial Eligibility Criteria
COVID-19
Lung-MAP
Tolerability in Cancer Clinical Trials
Analyses
Data Driven Insights
About Breakthrough Therapies
Search Breakthrough Therapies
Patient Resources
Education
Prevention, Detection, & Diagnosis
Clinical Trials
Find a Cancer Center
Glossary of Terms
Events
Upcoming Events
Past Events
Annual Meeting
Friends-Alexandria Blueprint Forum
News
In The News
Blog: Engaging Innovation
Press Releases
Publications
Donate
Search
Navigation Toggle
About
About Friends
Celebrating 25 Years
Team
Board of Directors
Financials & Policies
Projects
View All Projects
Research Partnerships
ctDNA
HRD Harmonization Project
Tumor Mutational Burden
Real-World Evidence
Policy & Regulatory Initiatives
Cell Therapies
Clinical Trial Eligibility Criteria
COVID-19
Lung-MAP
Tolerability in Cancer Clinical Trials
Analyses
Data Driven Insights
About Breakthrough Therapies
Search Breakthrough Therapies
Patient Resources
Education
Prevention, Detection, & Diagnosis
Clinical Trials
Find a Cancer Center
Glossary of Terms
Events
Upcoming Events
Past Events
Annual Meeting
Friends-Alexandria Blueprint Forum
News
In The News
Blog: Engaging Innovation
Press Releases
Publications
Donate
twitter
linkedin
youtube
Keyword search
Submit
Search
Close
Shaping the Future of Emerging Immunotherapies and Cell Therapies
Shaping the Future of Emerging Immunotherapies and Cell Therapies